Q: Hi Peter, the Bausch chart is turning up; your thoughts ? Thank you.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: hello 5i:
can you comment on ABBV's earnings. Mostly interested in the companies outlook. Is this still a hold?
thanks
Paul L
can you comment on ABBV's earnings. Mostly interested in the companies outlook. Is this still a hold?
thanks
Paul L
Q: Peter; I read the earnings, forecasts etc - looked good- what doesn’t the street like to dump it? Thanks
Rod
Rod
Q: I have a largish position in JNJ and see there is an offer to exchange some or all for a stake in KVUE at a 7% market discount which puts cost close to the IPO price of KVUE based on July 24 AM market price.
What to do - exchange some or all, ignore or buy KVUE separately rather than end up with a likely odd lot?
What to do - exchange some or all, ignore or buy KVUE separately rather than end up with a likely odd lot?
Q: Comments on the most recent quarter? And the 5% drawdown is probably just profit taking maybe your thoughts? I’m a long term holder of course but still interested in what you thought.
Q: Hi 5i, Well has been busy this month with acquisition of CarePlus and strategic alliance with MCI. With MCI it mentions AI opportunities in health platform.
Please provide your thoughts on these two events.
Thx.
Please provide your thoughts on these two events.
Thx.
Q: This takes one step forward and then three steps back. I'm down around 10% or so which is not the end of the world however, I just don't feel comfortable with it. Do you think I need more patience? There seems to be a lot of selling pressure on it which makes me nervous. Thanks.
Q: I am up 100% on NVO. LLY has just received an upgrade and am wondering if I should take profits on NVO and move into LLY or just add some LLY and let NVO run. In your opinion are they too much alike to hold both?
Thank you
Mike
Thank you
Mike
Q: WELL appears to be a reasonable recession-resistant investment, and management seems solid to me. Questions:
- How similar is TDOC's business model in comparison, and can WELL differentiate itself enough with its expansion into the U.S. ?
- Can 5i envision any other different avenues of growth for WELL to expand it's offerings within the health sector ?
- Is its current balance sheet sound, and can this company endure a rising interest rate environment ?
Thanks.
- How similar is TDOC's business model in comparison, and can WELL differentiate itself enough with its expansion into the U.S. ?
- Can 5i envision any other different avenues of growth for WELL to expand it's offerings within the health sector ?
- Is its current balance sheet sound, and can this company endure a rising interest rate environment ?
Thanks.
-
Illumina Inc. (ILMN $101.80)
-
Intuitive Surgical Inc. (ISRG $476.16)
-
AbbVie Inc. (ABBV $210.60)
-
Eli Lilly and Company (LLY $711.68)
-
Health Care Select Sector SPDR (XLV $138.17)
-
Vanguard Health Care ETF (VHT $256.46)
-
iShares U.S. Healthcare ETF (IYH $58.23)
Q: Pls ahare your favorite health stocks or ETFs. I am looking for growth - medium risk. Thanks
-
Illumina Inc. (ILMN $101.80)
-
Intuitive Surgical Inc. (ISRG $476.16)
-
Eli Lilly and Company (LLY $711.68)
-
Vanguard Health Care ETF (VHT $256.46)
-
iShares U.S. Healthcare ETF (IYH $58.23)
Q: Would advise your top picks in Us health care stocks or STFs with moderate risk. Yhanks
Q: Inmode's share price recently had a sizeable increase, presumably due the guidance it released. Would you expect a further increase based on that guidance? What are the prospects for the company going forward and where do you see the share price going from here, for the short as well as long term? Many thanks for your excellent service.
-
Constellation Software Inc. (CSU $4,549.91)
-
Brookfield Renewable Partners L.P. (BEP.UN $35.16)
-
WSP Global Inc. (WSP $285.87)
-
Stantec Inc. (STN $153.25)
-
Descartes Systems Group Inc. (The) (DSG $140.22)
-
FirstService Corporation (FSV $276.50)
-
TMX Group Limited (X $55.93)
-
TFI International Inc. (TFII $133.86)
-
ATS Corporation (ATS $38.06)
-
Kinaxis Inc. (KXS $194.59)
-
Shopify Inc. Class A Subordinate Voting Shares (SHOP $196.52)
-
goeasy Ltd. (GSY $209.13)
-
GDI Integrated Facility Services Inc. Subordinate Voting Shares (GDI $27.30)
-
EQB Inc. (EQB $101.38)
-
Trisura Group Ltd. (TSU $41.10)
-
WELL Health Technologies Corp. (WELL $4.92)
-
Boyd Group Services Inc. (BYD $224.13)
Q: Please list companies in your portfolios that have returned in excess of 100% over the last 5 years.
Please also show their % returns.
Thank you.
Please also show their % returns.
Thank you.
Q: Hi,
Can you comment on the share buy back? Generally, what is the reasoning for buying back and canceling shares?
Thanks
Paul
Can you comment on the share buy back? Generally, what is the reasoning for buying back and canceling shares?
Thanks
Paul
-
NVIDIA Corporation (NVDA $177.99)
-
AbCellera Biologics Inc. (ABCL $4.39)
-
Recursion Pharmaceuticals Inc. (RXRX $4.94)
Q: Abcellera is up 16% over 5 days. Any news driving this ?
Q: Hi 5i team. Can I have your thoughts on this company as an investment. Recently it's gotten a few upgrades in its target price.
Thanks Ken
Thanks Ken
Q: I have been hanging on to Covalon as it is in my RIF. Is there any future for this Company, or should it be disposed of to the graveyard littered with broken Companies?
Thank you Gordo
Thank you Gordo
Q: I've been continuing to hold NBLY and watching it continue to drop. It is now a 1% portfolio position. I read your answer about NBLY yesterday and wasn't entirely encouraged by the forward P/E and margins. For a 40 y/o investor who holds this stock in a LIRA (long term horizon), are the prospects so bright that we should wait out the eventual recovery? Or should I look to buy something with better potential in the shorter term?
Q: Peter; I asked last week - maybe it didn’t make it- about if buying LLY while owing Edwards would be duplication- or diversification ? Thanks.
Rod
Rod
-
Biogen Inc. (BIIB $139.31)
-
Intuitive Surgical Inc. (ISRG $476.16)
-
AbbVie Inc. (ABBV $210.60)
-
Eli Lilly and Company (LLY $711.68)
-
Repligen Corporation (RGEN $124.79)
Q: Repligen is trading close to the 52-week low and would welcome your analysis of their recent operating performance and market potential looking forward. Post-pandemic and mindful of competitors in the same space does their stock have any opportunity to excel in the coming year, and if held as a position in a long-term growth portfolio, could you please rank the appeal of Repligen in descending order versus your go-to favorites in the same general space. Thanks kindly for your thoughts.